Kailos Genetics Announces Strategic Investment and Partnership with In-Q-Tel

Posted on July 12, 2017 By Corinne Jones News

Kailos Genetics, a personalized medicine company offering a leading-edge suite of tools for next-generation sequencing (NGS)-based assays, today announced a strategic partnership with and investment from In-Q-Tel, Inc. (IQT)

Please Sign-up / Sign-in to read the entire article.

by Corinne Jones

Website

LIMS forum content by LIMS forum members is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at www.limsforum.com.